Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MacroGenics’ margetuximab beats Herceptin in phase 3 .A phase 3 trial of MacroGenics’ margetuximab in HER2-positive metastatic breast cancer patients has met its primary endpoint. The anti-HER2 antibody … Continue reading
Original Article: #news #biotech MacroGenics’ margetuximab beats Herceptin in phase 3